| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $20.0M | — | — |
| R&D Expense | $6.0M | — | +202.8% |
| SG&A Expense | $4.8M | — | +78.1% |
| Operating Income | -$10.8M | — | -130.7% |
| Pre-tax Income | -$10.1M | — | -122.5% |
| Income Tax | $10K | — | +0.0% |
| Net Income | -$10.1M | — | -122.1% |
| EPS (Basic) | -$0.18 | — | -20.0% |
| EPS (Diluted) | -$0.18 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $79.3M | -15.6% | +397.8% |
| Short-term Investments | $11.3M | +74.8% | — |
| Current Assets | $92.3M | -8.9% | +449.9% |
| Total Assets | $95.8M | -8.6% | +381.7% |
| Current Liabilities | $10.5M | +4.2% | +13.2% |
| Total Liabilities | $11.5M | +3.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.8M | — | -483.2% |
| Capital Expenditures | $32K | — | -52.0% |
| Investing Cash Flow | -$4.8M | — | -6990.0% |
| Financing Cash Flow | -$38K | — | — |
| Free Cash Flow | -$9.9M | — | -462.5% |
| +11.2% |
| Stockholders' Equity | $84.4M | -10.1% | +779.4% |